Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

495 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endogenous testosterone density as ratio of endogenous testosterone levels on prostate volume predicts tumor upgrading in low-risk prostate cancer.
Porcaro AB, Gallina S, Bianchi A, Cerrato C, Tafuri A, Rizzetto R, Amigoni N, Orlando R, Serafin E, Gozzo A, Migliorini F, Antoniolli SZ, Lacola V, De Marco V, Brunelli M, Cerruto MA, Siracusano S, Antonelli A. Porcaro AB, et al. Among authors: migliorini f. Int Urol Nephrol. 2021 Dec;53(12):2505-2515. doi: 10.1007/s11255-021-03008-0. Epub 2021 Oct 22. Int Urol Nephrol. 2021. PMID: 34677784 Free PMC article.
Investigative clinical study on prostate cancer: on the role of the pretreatment total PSA to free testosterone ratio in selecting different biology groups of prostate cancer patients.
Porcaro AB, Migliorini F, Romano M, Petrozziello A, Antoniolli SZ, Rubilotta E, Lacola V, Sava T, Ghimenton C, Caruso B, Monaco C, Comunale L. Porcaro AB, et al. Among authors: migliorini f. Int Urol Nephrol. 2010 Sep;42(3):673-81. doi: 10.1007/s11255-009-9669-z. Epub 2009 Nov 10. Int Urol Nephrol. 2010. PMID: 19902378
Investigative clinical study on prostate cancer part II: on the role of the pretreatment total PSA to free testosterone ratio as a marker assessing prostate cancer prognostic groups after radical retropubic prostatectomy.
Porcaro AB, Monaco C, Romano M, Petrozziello A, Rubilotta E, Lacola V, Sava T, Ghimenton C, Caruso B, Antoniolli SZ, Migliorini F, Comunale L. Porcaro AB, et al. Among authors: migliorini f. Urol Int. 2010;85(2):152-8. doi: 10.1159/000318632. Epub 2010 Jul 8. Urol Int. 2010. PMID: 20616526
Investigative clinical study on prostate cancer part III: exploring total PSA and free testosterone distributions and linear correlations in groups and subgroups of operated prostate cancer patients according to the total PSA/FT ratio.
Porcaro AB, Petrozziello A, Romano M, Sava T, Ghimenton C, Caruso B, Migliorini F, Zecchini Antoniolli S, Rubilotta E, Lacola V, Monaco C, Comunale L. Porcaro AB, et al. Among authors: migliorini f. Urol Int. 2010;85(4):406-9. doi: 10.1159/000319966. Epub 2010 Oct 15. Urol Int. 2010. PMID: 20948186
Investigative clinical study on prostate cancer part IV: exploring functional relationships of total testosterone predicting free testosterone and total prostate-specific antigen in operated prostate cancer patients.
Porcaro AB, Petrozziello A, Migliorini F, Lacola V, Romano M, Sava T, Ghimenton C, Caruso B, Zecchini Antoniolli S, Rubilotta E, Monaco C, Comunale L. Porcaro AB, et al. Among authors: migliorini f. Urol Int. 2011;86(4):399-406. doi: 10.1159/000324267. Epub 2011 Apr 20. Urol Int. 2011. PMID: 21508618
Investigative clinical study on prostate cancer part VII: prolactin and the pituitary-testis-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population.
Porcaro AB, Ghimenton C, Petrozziello A, Migliorini F, Romano M, Sava T, Caruso B, Cocco C, Antoniolli SZ, Lacola V, Rubilotta E, Monaco C, Comunale L. Porcaro AB, et al. Among authors: migliorini f. Anticancer Res. 2011 Nov;31(11):3913-20. Anticancer Res. 2011. PMID: 22110219
495 results